BRIEF-Neuralstem jumps in premarket after FDA OK's spinal cord injury trial

NEW YORK Mon Jan 14, 2013 8:14am EST

NEW YORK Jan 14 (Reuters) - Neuralstem Inc : * Jumps 15.3 percent to $1.43 in premarket after FDA ok's spinal cord injury trial

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.